Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician, Doctor Bangkok.
Last reviewed: October 2026
Tirzepatide (brand name Mounjaro) is a prescription-only injectable medicine that targets two hormone receptors, GIP and GLP-1, to reduce appetite and improve metabolic health. It has been available in Thailand through authorised channels since May 2025. Since September 2026, Thai FDA rules require a valid prescription from a licensed physician. A suitability review and baseline blood tests are required before any prescription is issued.
You want to know if you can get tirzepatide prescribed in Bangkok, properly, by a real doctor. The short answer is yes. Mounjaro is legally available here, and a qualified physician can assess whether it suits you, run the baseline tests, and prescribe through authorised channels.
Getting that assessment done correctly is what matters. The wrong dose, the wrong candidate, or a product sourced outside the licensed supply chain can cause real harm. If you are an expat or visiting Bangkok for medical care, here is what to expect: how the medicine works, who qualifies, what monitoring looks like, and how to arrange a review around your schedule.

What Tirzepatide Does
Tirzepatide acts on two gut hormones released after eating: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Activating both receptors together reduces appetite more strongly than targeting either one alone, slows gastric emptying so you feel full longer, and improves how your body handles blood glucose.
This dual-agonist action is what sets tirzepatide apart from semaglutide, which targets GLP-1 only. The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, reported a mean body weight reduction of up to 22.5% at the highest dose (15 mg) over 72 weeks in adults with obesity without type 2 diabetes, measured in participants who remained on treatment; the intention-to-treat estimate was approximately 20.9%. That is the strongest published efficacy figure for this drug class to date.
The medicine is given as a once-weekly subcutaneous injection using a prefilled pen. Doses are started low and increased gradually over several weeks to reduce side effects. The escalation schedule is set by your prescribing physician based on your tolerance and response. For a direct comparison with semaglutide, the Doctor Bangkok GLP-1 guide covers the evidence in detail.
Brand Names and Local Availability
In Thailand, tirzepatide is sold under the brand name Mounjaro, manufactured by Eli Lilly and distributed through Zuellig Pharma Thailand. Mounjaro has been available through authorised medical channels since May 2025. Zepbound, the obesity-indicated brand used in some other countries, is not separately registered in Thailand as of this review date.
Since September 2026, the Thai FDA classifies tirzepatide as a prescription-only medicine. Purchasing it from social media sellers, grey-market sources, or online pharmacies without a prescription is illegal. Counterfeit products, improper cold-chain storage, and incorrect dosing are all documented risks in informal supply chains.
If a seller does not require a consultation first, that is a warning sign, not a convenience.

Who May Be a Candidate for Tirzepatide in Bangkok
Tirzepatide is indicated for adults with obesity, or with overweight alongside at least one weight-related condition such as type 2 diabetes, high blood pressure, or raised cholesterol. A physician will look at your full clinical picture, not just a number on a scale. You can use the BMI Calculator Bangkok tool for a quick reference before your consultation.
Certain people should not use tirzepatide. It is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. It is not prescribed during pregnancy. Active pancreatitis is a reason for caution and requires discussion with your physician before starting tirzepatide; it is listed as a warning in the prescribing information, not a formal contraindication.
If you have type 2 diabetes and are already on insulin or a sulfonylurea, your prescribing physician needs to know before anything is prescribed. Adding tirzepatide in that context requires careful dose management to avoid low blood glucose. This is exactly the kind of detail a proper suitability consultation is designed to catch.
Monitoring While on Tirzepatide
Starting tirzepatide without baseline blood tests is not good clinical practice. Before any prescription is issued, a responsible physician will want fasting blood glucose, HbA1c (your three-month average blood sugar), liver enzymes (ALT and AST), kidney function, a lipid panel, thyroid function, and a full blood count.
Once you are on tirzepatide, ongoing monitoring matters. Pancreatitis risk is real, though uncommon. Persistent, severe abdominal pain that radiates to the back warrants stopping the medication and getting assessed the same day. Gallbladder problems are also associated with rapid weight loss and should be raised with your doctor if you notice upper right abdominal pain.
Common side effects are mostly gastrointestinal: nausea, vomiting, diarrhoea, and constipation, especially during dose escalation. These tend to ease as your body adjusts. They need to be discussed honestly at your review, particularly if you have any existing digestive condition.
For patients with cardiometabolic risk factors, establishing a cardiovascular baseline at the start is useful. The Cardiovascular Risk Calculator Bangkok tool gives useful context before your consult.
How to Arrange a Tirzepatide Consultation in Bangkok
Getting a proper consultation should not mean taking time off work or navigating a hospital referral system in a language you do not speak. Doctor Bangkok operates 24 hours a day, seven days a week, at a private clinic on Sukhumvit Soi 13, a short walk from BTS Nana and BTS Asok. Walk-ins are accepted at any hour.
If you would rather not come to the clinic, a doctor can come to your hotel or condo anywhere in Bangkok within one hour. The doctor-at-your-hotel service is available day or night and covers the full suitability review, including requesting baseline blood tests.
The consultation covers your medical history, a clinical assessment, and baseline blood work. Results are reviewed before any prescription is issued. For expats on a short visit, we can work around your schedule and provide clinical documentation your home-country doctor can use. A same-day appointment is available. For a broader picture of what medical weight management in Bangkok looks like, the weight-loss injections Bangkok page covers the full range of options.
Tirzepatide suitability consultations at Doctor Bangkok, 24 hours a day. Walk in to our clinic on Sukhumvit Soi 13, or a doctor comes to your hotel or condo within one hour. We run baseline blood tests, review your full clinical history, and prescribe only licensed Mounjaro through authorised supply channels. Contact Doctor Bangkok to arrange your review today.
FAQ
Dr. Ponlawat Pitsuwan
Physician, Doctor Bangkok
a private medical clinic in central Bangkok open 24 hours a day, with a doctor-on-call service that reaches your hotel or condo within one hour. He sees expats, residents, and medical tourists for weight management consultations, metabolic health assessments, tirzepatide suitability reviews, and ongoing monitoring. His focus is straightforward, evidence-based care delivered in plain language.
References
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022. DOI: 10.1056/NEJMoa2206038
- US FDA. Mounjaro (tirzepatide) Prescribing Information (revised 2026). accessdata.fda.gov
- Eli Lilly and Company. What is the recommended storage for Mounjaro (tirzepatide) single-dose pen? Lilly US Medical Information FAQ.
- Zuellig Pharma. Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand. May 2025.
- Eli Lilly and Company. Lilly’s tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1. Investor News Release, April 2022.
- Eli Lilly and Company. When is Mounjaro (tirzepatide) contraindicated? Lilly US Medical Information FAQ.
The information in this article is for educational purposes only and does not constitute medical advice. It should not be used to self-diagnose or replace a consultation with a qualified physician. If you have concerns about your health, contact a licensed medical professional. For appointments at Doctor Bangkok, visit doctorbangkok.co.th.




